| Market Cap | ₹30,243Cr |
| ROE | 18.88% |
| P/E Ratio(TTM) | 40.12 |
| EPS(TTM) | 46.96 |
| P/B Ratio | 7.95 |
| Dividend Yield | 0.80% |
| Industry P/E | 31.99 |
| Book Value | 237.10 |
| Debt to Equity | 0.01 |
| Face Value | 1 |
| Managing Director | Nikhil Chopra |
| Founded | 1976 |
| NSE Symbol | JBCHEPHARM |
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| Emcure Pharmaceuticals | NA (0.00%) | 32.75 | ||
| Wockhardt | NA (0.00%) | -450.11 | ||
| Natco Pharma | NA (0.00%) | 9.85 | ||
| Granules India | NA (0.00%) | 25.30 |